1.0Center for Gastrointestinal Biology and Disease/cgibdAmy Smither/cgibd/author/amy-smither/rich600338<blockquote class="wp-embedded-content" data-secret="uQMV2hhZT3"><a href="/cgibd/directory/anna-mae-diehl-md/">Anna Mae Diehl, MD</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="/cgibd/directory/anna-mae-diehl-md/embed/#?secret=uQMV2hhZT3" width="600" height="338" title="“Anna Mae Diehl, MD” — Center for Gastrointestinal Biology and Disease" data-secret="uQMV2hhZT3" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript"> /* <![CDATA[ */ /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); /* ]]> */ </script> /cgibd/wp-content/uploads/sites/466/2022/05/Diehl.jpg235300Research Summary Dr. Diehl has been studying metabolic dysfunction associated steatotic liver disease (MASLD) for 30 years ago. She was one of the first to describe the similar hepatic histologic features but contrasting clinical parameters of patients with MASLD (then dubbed NAFLD) and alcoholic liver disease. Since then, she has worked with colleagues to apply … Read more